- Research news
- Open Access
Zebrafish on drugs
Genome Biology volume 1, Article number: spotlight-20001122-02 (2000)
In the November 21 Proceedings of the National Academy of Sciences, Peterson et al. describe a screen for chemicals that can be used to interfere with, and time, developmental events in zebrafish (Proc Natl Acad Sci USA 2000, 97:12965-12969). Zebrafish eggs were arrayed three to a well in 96-well plates, along with one of 1,100 synthetic small molecules. The developing embryos were screened once a day for three days for defects in the central nervous system, the cardiovascular system, pigmentation, or ear development, with one person capable of screening approximately 400 compounds a day. Approximately 2% of the compounds were generally lethal or caused widespread necrosis, but approximately 1% of the compounds affected a specific aspect of one system under study. Peterson et al. demonstrated the utility of such probes by adding and washing away a particular chemical at different times, thus determining that a critical stage for ear development occurs between 14 and 26 hours post-fertilization. Further insight may come from isolation of the proteins targeted by the chemicals, using procedures such as affinity chromatography.
Proceedings of the National Academy of Sciences, [http://www.pnas.org/]
Target-oriented and diversity-oriented organic synthesis in drug discovery.
Chemistry or biology: which comes first after the genome is sequenced?
About this article
Cite this article
Wells, W. Zebrafish on drugs. Genome Biol 1, spotlight-20001122-02 (2000). https://doi.org/10.1186/gb-spotlight-20001122-02
- Nervous System
- Central Nervous System
- Small Molecule
- Cardiovascular System
- Affinity Chromatography